Skip to content

Prospective, multicenter, open-label, investigator-initiated, post marketing interventional study

The use of physiologic assessment and functional SYNTAX score in influencing the treatment strategy for Multi-Vessel Disease (MVD) patients involving intermediate decisions compared to conventional angiography and anatomical SYNTAX score in a real-wo

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
TCTR
Registry ID
TCTR20190915003
Enrollment
566
Registered
2019-09-15
Start date
2020-07-18
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stable angina Recent and stabilized NSTEMI coronary angiography

Interventions

None listed

Sponsors

Siriraj Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Age >18 years Willing to participate and able to understand, read and sign the informed consent document before the planned procedure Eligible for coronary angiography and/or percutaneous coronary intervention Stable angina Recent and stabilized NSTEMI Angiographic inclusion criteria Coronary artery disease in two or more native major epicardial vessels or their braches by coronary angiogram with visually assessed de novo coronary stenosis in which one of the lesion has the physiological severity of the lesion is in question (50-90% diameter stenosis). All lesions are amenable to revascularization

Exclusion criteria

Exclusion criteria: - Terminal disease with life expectancy of less than 12 months - Any patient who at the time of planned angiography has ongoing ischemic symptoms - Angiography performed in the context of primary PCI of STEMI - Acute coronary syndrome with difficulty in assessing the culprit lesion - Pregnancy - Severe aortic stenosis - Significant valvular heart disease indicated for concomitant valve surgery - Cardiogenic shock or hemodynamic instability - Contraindication to adenosine - Previous CABG - Additional investigations planned for the assessment of myocardial viability. - Severe asthma Angiographic exclusion criteria - Heavily calcified or tortuous vessels that in the opinion of the investigator would result in uncrossable of pressure wire

Design outcomes

Primary

MeasureTime frame
Change in treatment strategy after physiologic assessment At Day 1 FFR and Coronary Angiography,Healthcare costs At 12 months after treatment From cost of procedures

Secondary

MeasureTime frame
The percentage rate of concordance between FFR and RFR At day 1 & at 12 month after treatment FFR and RFR,The percentage rate of concordance in functional SS between RFR and FFR At 12 months after treatment FFR and RFR,Clinical outcomes in concordance | discordant group At day 1 , At day 30 and at 12 month after treatment FFR and RFR,Composite of MACCE (all-cause death, documented MI, stroke or unplanned revascularization) 12 month after treatment Patient reporting,Rates of individual components of MACE 12 month after treatment Patient reporting,Level of agreement in the decision making strategy At Day 1 FFR and RFR,Functional SYNTAX score calculation based on FFR At Day 1 FFR,Change in health status of patients from baseline to one year At 12 month after treatment EQ-5D-5L

Countries

Thailand

Contacts

Public ContactNattawut Wongpraparut

Siriraj hospital

wongpraparut@yahoo.com089 795 4422

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026